Skip to main content
. Author manuscript; available in PMC: 2014 Aug 7.
Published in final edited form as: BJU Int. 2012 Feb 28;110(8):1122–1128. doi: 10.1111/j.1464-410X.2012.10986.x

TABLE 2.

Biopsy characteristics of men with Gleason 8 – 10 prostate cancer with favourable (pT2 – pT3a) and unfavourable (pT3b or N1) pathology

Biopsy Gleason 8 – 10 Favourable Unfavourable P
N (%): 842 656 (77.9) 186 (22.1)
 Biopsy Gleason:
  8 602 (71.5) 507 (77.3) 95 (51.1)
  3 + 5 54 (6.4) 48 (7.3) 6 (3.2)
  4 + 4 414 (49.2) 353 (53.8) 61 (32.8)
  5 + 3 14 (1.7) 11 (1.7) 3 (1.6) < 0.001
  9 228 (27.1) 143 (21.8) 85 (45.7)
  4 + 5 138 (16.4) 98 (14.9) 40 (21.5)
  5 + 4 45 (5.3) 25 (3.8) 20 (10.8)
  10, 5 + 5 12 (1.4) 7 (1.1) 5 (2.7)
Positive cores:
  Median (range) 4 (1 – 16) 3 (1 – 15) 4.5 (1 – 16) < 0.001
  1 – 3, n (%) 321 (49.2) 273 (52.2) 48 (36.9) 0.002
  >, n (%)3 332 (50.8) 250 (47.8) 82 (63.1)
High-grade cores:
  Median (range) 2 (1 – 16) 2 (1 – 10) 2 (1 – 16) < 0.001
  >1, n (%) 353 (54.4) 263 (50.3) 90 (69.2) < 0.001
  Total cores, median (range) 12 (3 – 60) 12 (3 – 60) 12 (4 – 18) 0.001
  Percentage cores positive, median (range) 40 (5 – 100) 31 (5 – 100) 54 (8 – 100) < 0.001
PPC:
  Median (range) 70 (5 – 100) 60 (5 – 100) 90 (25 – 100) 0.065
  0 to <50%, n (%) 196 (30.3) 181 (34.7) 15 (12.0) < 0.001
  ≥50 to 100%, n (%) 450 (69.7) 340 (65.3) 110 (88.0)
N (%):
 Positive core laterality:
  Bilateral 209 (46.8) 159 (25.6) 50 (30.5)
  Right 118 (26.4) 98 (15.8) 22 (13.4) 0.4
  Left 120 (26.8) 98 (15.8) 20 (12.2)
 Positive core location
  Apex 254 (77.2) 197 (75.8) 57 (82.6) 0.2
  Mid-gland 258 (78.4) 198 (76.2) 60 (87.0) 0.06
  Base 237 (72.0) 174 (66.9) 63 (91.3) < 0.001
 histologic features on biopsy:
  PNI 207 (30.4) 147 (26.9) 60 (44.1) < 0.001
  Atypia 94 (13.8) 77 (14.1) 17 (12.5) 0.6
  HGPIN 108 (15.8) 94 (17.2) 14 (10.3) 0.048

HGPIN, high-grade prostatic intraepithelial neoplasia; PNI, perineural invasion; PPN, maximum percentage involvement of each positive core.